Nanopacli Injection

Nanopacli 100 mg Injection is a microtubule inhibitor that’s used to treat metastatic breast cancer in patients who have failed combination chemotherapy or relapsed within 6 months of adjuvant chemotherapy. Nanopacli 100 mg can be combined with carboplatin as a first-line treatment for locally advanced or metastatic non-small cell lung cancer in patients who cannot undergo radical surgery or radiation therapy.